{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Fail to engraft by D28"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Fail to maintain ANC >100 for 5 years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Graft failure defined as failure to reach ANC of \\>500/uL for 3 consecutive days by day 28, or irreversible decrease in ANC to \\<100 after an established donor graft. A reduction in ANC as result of relapse is not considered graft failure","groups":[{"description":"All participants in single arm study received CD45RA+ T cell depletion PBSC transplant and IV Methotrexate and tacrolimus for GVHD prophylaxis","id":"OG000","title":"Overall Study Participants"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Graft Failure","type":"PRIMARY","unitOfMeasure":"Participants"}